Seroquel TM treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia. A multicentre, placebo-controlled, double-blind comparison of low and high dosage regimens

Author： Link C.G.G.   Arvanitis L.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 346-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

By Andrezina Raisa   Josiassen Richard   Marcus Ronald   Oren Dan   Manos George   Stock Elyse   Carson William   Iwamoto Taro  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 281-292

Springer Publishing Company

Access to resources Recommend Favorite

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Garcia Esther  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study

By Murphy K.R.  

Clinical Drug Investigation, Vol. 20, Iss. 5, 2000-11 ,pp. : 337-349

Adis International

Access to resources Recommend Favorite

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Wallace Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite

Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

By Poyurovsky M.   Koren D.   Gonopolsky I.   Schneidman M.   Fuchs C.   Weizman A.   Weizman R.  

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite